Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Definite IPF”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT02763540
What this trial is testing

Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD

Who this might be right for
Non Definite IPFInterstitial Lung Diseases
University Hospital, Montpellier 21
Not applicableUnknownNCT05174741
What this trial is testing

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Who this might be right for
PneumoniaPulmonary FibrosisTuberculosis+2 more
Riphah International University 20
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 103
Not applicableStudy completedNCT04614441
What this trial is testing

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 214
Not applicableActive Not RecruitingNCT07080125
What this trial is testing

A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

Who this might be right for
Interstitial Lung DiseasesSystemic Sclerosis Associated Interstitial Lung Disease
Boehringer Ingelheim 2,000